| Followers | 200 |
| Posts | 25596 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Thursday, December 15, 2022 8:26:19 PM
Very interesting H.
This is organized by a UK company that as a business organizes conferences like this, and honestly, looks more like someone trying to create a business in this “niche”, as they call their conference products. They invited large pharma and companies that would be the best sources of income first. It’s not till March and if it were an important or useful event, depending on whether NWBO is still fully independent, they could probably attend if they wanted to do so.
I vaguely think that Dr. Liau or others were maybe scheduled to attend last year but then didn’t or attended but we got no news. I vaguely remember it, but at this stage you never know what the plan is likely to be.
The reality is it also looks, generally to me, like often these sorts of events start on the East Coast and then they remember we have a West Coast, in terms of people like Dr. Liau. Who if they really wanted a top person would seek her early, but she’s actually very busy. Maybe some of these attendees that sign up first are not so busy. Or are more executives at big pharma. Some people just attend a lot of conferences looking for other companies to network with, etc., and some of those people are great talkers and have big titles and potentially access to research monies, so they are an attractor for others to register.
There could be many reasons why they are focused in certain ways. Or why a small co at this stage in its existence might not be spending a lot planning to be at conferences right now.
I do not think it is odd. I would rather with their limited means right now, that the company remain focused. Dr. Liau would be the appropriate invitee and also, since it is organized by a UK company, Dr. Ashkan.
There could be many drivers for NWBO and the various doctors to be focused elsewhere at the moment and not be planning to go to every conference from the get go. But the also could yet decide to attend or even maybe present or be a guest. I would bet a conference like this would want them more than they might want to take the time away from their schedules to attend right now.
This is organized by a UK company that as a business organizes conferences like this, and honestly, looks more like someone trying to create a business in this “niche”, as they call their conference products. They invited large pharma and companies that would be the best sources of income first. It’s not till March and if it were an important or useful event, depending on whether NWBO is still fully independent, they could probably attend if they wanted to do so.
I vaguely think that Dr. Liau or others were maybe scheduled to attend last year but then didn’t or attended but we got no news. I vaguely remember it, but at this stage you never know what the plan is likely to be.
The reality is it also looks, generally to me, like often these sorts of events start on the East Coast and then they remember we have a West Coast, in terms of people like Dr. Liau. Who if they really wanted a top person would seek her early, but she’s actually very busy. Maybe some of these attendees that sign up first are not so busy. Or are more executives at big pharma. Some people just attend a lot of conferences looking for other companies to network with, etc., and some of those people are great talkers and have big titles and potentially access to research monies, so they are an attractor for others to register.
There could be many reasons why they are focused in certain ways. Or why a small co at this stage in its existence might not be spending a lot planning to be at conferences right now.
I do not think it is odd. I would rather with their limited means right now, that the company remain focused. Dr. Liau would be the appropriate invitee and also, since it is organized by a UK company, Dr. Ashkan.
There could be many drivers for NWBO and the various doctors to be focused elsewhere at the moment and not be planning to go to every conference from the get go. But the also could yet decide to attend or even maybe present or be a guest. I would bet a conference like this would want them more than they might want to take the time away from their schedules to attend right now.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
